Form 8-K - Current report:
SEC Accession No. 0001628280-18-003050
Filing Date
2018-03-12
Accepted
2018-03-09 21:14:59
Documents
1
Period of Report
2018-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K item5022018salarybonus8-k.htm 8-K 50017
  Complete submission text file 0001628280-18-003050.txt   51284
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 18681740
SIC: 2834 Pharmaceutical Preparations